Generic name |
sarilumab |
---|---|
Strength |
150 mg/1.14 mL 200 mg/ 1.14 mL |
Form |
pre-filled syringe or pre-filled pen for subcutaneous injection |
Special Authority criteria |
Approval period |
---|---|
For the treatment of rheumatoid arthritis (RA) when:
AND
|
First approval: 1 year Renewal: 1 year
|